期刊文献+

检测肺癌患者血清p53抗体的临床意义 被引量:10

Clinical Significance of Detecting Serum p53Antibody in Lung Cancer Patients
下载PDF
导出
摘要 目的:探讨检测肺癌患者血清p53抗体的临床意义。方法:采用酶联免疫吸附法检测120例肺癌患者血清p53抗体,并以30例肺部良性疾病患者和120例正常健康人作对照。结果:肺癌患者血清p53抗体水平明显高于肺部良性疾病患者和正常人(P<0.05),而正常人与肺部良性疾病患者间无显著性差异(P>0.05)。120例肺癌中26例p53抗体阳性,阳性率为21.7%,而30例肺部良性疾病患者和120例正常人无1例阳性。肺癌者血清p53抗体与肺癌细胞分化程度和临床分期有密切关系(P<0.01)。结论:检测血清p53抗体水平有助于肺部良恶性疾病的诊断及鉴别诊断。 Objective:To explore the clinical significance of detecting serum p53antibody in patients with lung cancer.Methods:Serum p53antibody were detected in120patients with lung cancer,30patients of them with benign pulmonary disease and120healthy individuals as control using enzyme linked immunosorbent assay.Results:The level of serum p53antibody in patients with lung cancer was significantly higher than that in patients with benign pulmonary disease and normal controls(P<0.05),but there was no significant difference between the patients with benign pulmonary disease and the normal individuals(P>0.05).Of the120patients with lung cancer21.7%(26/120)were positive for serum p53antibody,but all the30patients with benign pulmonary disease and120normal individuals were negative.The level of serum p53antibody in patients with lung cancer were closely related to cell differentiation and stage of lung cancer(P<0.01).Conclusion:Detection of serum p53antibody is helpful to differentiate the diagnosis of benign and malignant pulmonary diseases and to monitor the proceeding of lung cancer
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第8期551-553,共3页 Chinese Journal of Clinical Oncology
关键词 肺癌 血清 P53抗体 临床意义 酶联免疫吸附法 Lung cancer p53gene Serum p53antibody ELISA
  • 相关文献

参考文献9

  • 1[1]Hollstein M, Sidransky D, Vagelstein B, et al. p53 mutations in human cancers. Science, 1991, 253:49~53
  • 2[2]Sozzi G, Camey D. Molecular biology of lung cancer. Curr Opin Pulm Mod, 1998, 4(4): 207~212
  • 3[3]Soussi T, Legros Y, Lubin R, et al. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer,1994, 57:1~9
  • 4[4]Brambilla E,Brambilla C. p53 and lung cancer. Pathol Biol,1997, 45(10): 852~863
  • 5[5]Lubin R, Schlichtholz B, Teillaud JL, et al. p53 antibodies in patients with various types of cancer assay, identification and characterization. Clin Cancer Res, 1995, 1:1463~1469
  • 6[6]Soussi T. p53 antibodies in the sera of patients with various type of cancer: a review. Cancer Res, 2000,60:1777~1788
  • 7[7]Lenner P, Wiklund F, Emdin SO, et al. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study. Br J Cancer,1999, 79(5~6): 927~932
  • 8[8]Laudanski J, Burzykowski T, Niklinska W, et al. Prognostic value of serum p53 antibodies in patients with resected nonsmall cell lung cancer. Lung Cancer, 1998, 22:191~200
  • 9[9]Mack U, Ukena D,Montenarh M, et al. Serum anti-p53 antibodies in patients with lung cancer. Oncol Rep, 2000,7(3):669~674

同被引文献87

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部